[OTDev] Toxicology Ontology Perspectives and Roadmap
Barry Hardy barry.hardy at douglasconnect.comWed Dec 19 13:37:11 CET 2012
- Previous message: [OTDev] An obituary for Nicki Douglas
- Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]
Based on an OpenTox : EMBL-EBI Industry Programme Workshop two papers were published this year and are available online in Open Access mode from www.altex.ch: A Toxicology Ontology Roadmap ALTEX 29(2), 129 - 137 (2012) and Toxicology Ontology Perspectives ALTEX 29(2), 139 - 156 (2012) Barry Hardy (Douglas Connect and OpenTox), Gordana Apic (Cambridge Cell Networks), Philip Carthew (Unilever), Dominic Clark (EMBL-EBI), David Cook (AstraZeneca), Ian Dix (AstraZeneca & Pistoia Alliance), Sylvia Escher (Fraunhofer Institute for Toxicology & Experimental Medicine), Janna Hastings (EMBL-EBI), David J. Heard (Novartis), Nina Jeliazkova (Ideaconsult), Philip Judson (Lhasa Ltd.), Sherri Matis-Mitchell (AstraZeneca), Dragana Mitic (Cambridge Cell Networks), Glenn Myatt (Leadscope), Imran Shah (US EPA), Ola Spjuth (University of Uppsala), Olga Tcheremenskaia (Istituto Superiore di Sanità), Luca Toldo (Merck KGaA), David Watson (Lhasa Ltd.), Andrew White (Unilever), Chihae Yang (Altamira) I will be interested to hear from community members their interest and suggestions in progressing this area. best regards Barry Barry Hardy PhD Director Douglas Connect GmbH Baermeggenweg 14 4314 Zeiningen Switzerland
- Previous message: [OTDev] An obituary for Nicki Douglas
- Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]
More information about the Development mailing list